Lactobacillus rhamnosus GG Intake Modifies Preschool Children's Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Korpela, Katri ^a   Salonen, Anne ^a   Virta, Lauri J ^b   Kumpu, Minna ^c   Kekkonen, Riina A ^c   De Vos, Willem M ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c VALIO LTD   (Finland)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PLACEBO; PROBIOTIC AGENT; SULFONAMIDE PLUS TRIMETHOPRIM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL INFECTION; CHILD; CHRONIC DRUG ADMINISTRATION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; ESCHERICHIA COLI; FECES MICROFLORA; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION PREVENTION; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS; LONG TERM CARE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NONHUMAN; POPULATION ABUNDANCE; PRESCHOOL CHILD; PREVOTELLA MELANINOGENICA; RUMINOCOCCUS; SIDE EFFECT; ADULT; AGED; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FECES; INTESTINE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FECES; HUMANS; INTESTINES; LACTOBACILLUS RHAMNOSUS; MACROLIDES; MICROBIOTA; MIDDLE AGED; PENICILLINS; PLACEBOS; PROBIOTICS;

EID: 84965163813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154012     Document Type: Article

References (56)

1. Chai G, Governale L, McMahon AW, Trinidad JP, Staffa J, Murphy D (2012) Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics 130: 23-31. doi: 10.1542/peds.2011-2879 PMID: 22711728.
2. Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH (2011) Probiotics for the prevention of pediatric antibiotic- Associated diarrhea. Cochrane Database Syst Rev 11.
3. Blaser M (2011) Stop the killing of beneficial bacteria. Nature 476: 393-394. doi: 10.1038/476393a PMID: 21866137.
4. McFarland LV (2008) Anti biotic- Associated diarrhea: Epidemiology, trends and treatment. Future Microbiology 3: 563-578.
5. De La Cochetiere MF, Durand T, Lepage P, Bourreille A, Galmiche JP, Dore J. (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43: 5588- 5592. PMID: 16272491.
6. Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. Plos Biology 6: 2383-2400.
7. Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L (2010) Short- Term antibiotic treatment has differing long- Term impacts on the human throat and gut microbiome. PLoS One 5: E9836. doi: 10.1371/journal.pone.0009836 PMID: 20352091.
8. Jernberg C, Lofmark S, Edlund C, Jansson JK (2010) Long- Term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology-Sgm 156: 3216-3223.
9. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay B (2008) Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 76: 4726- 4736. doi: 10.1128/IAI.00319-08 PMID: 18678663.
10. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young V (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-2375. doi: 10.1128/IAI.01520-08 PMID: 19307217.
11. Antunes LCM, Han J, Ferreira RBR, Lolic P, Borchers CH, Finlay B (2011) Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 55: 1494-1503. doi: 10.1128/AAC.01664-10 PMID: 21282433.
12. Modi SR, Collins JJ, Relman DA (2014) Antibiotics and the gut microbiota. J Clin Invest 124: 4212- 4218. doi: 10.1172/JCI72333 PMID: 25271726.
13. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, et al. (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488: 621-626. doi: 10.1038/nature11400 PMID: 22914093.
14. Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, et al. (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158: 705-721. doi: 10.1016/j.cell.2014.05.052 PMID: 25126780.
15. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB (2005) Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: Role of host genetics, antigen, and interleukin-13. Infect Immun 73: 30-38. PMID: 15618138.
16. Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, et al. (2012) Early life antibiotic- driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 13: 440-447. doi: 10.1038/embor.2012.32 PMID: 22422004.
17. Thuny F, Richet H, Casalta J, Angelakis E, Habib G, Raoult D (2010) Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. Plos One 5: E9074. doi: 10.1371/journal.pone.0009074 PMID: 20161775.
18. Ajslev TA, Andersen CS, Gamborg M, Sorensen TIA, Jess T (2011) Childhood overweight after establishment of the gut microbiota: The role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes 35: 522-529.
19. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser M (2013) Infant antibiotic exposures and early life body mass. Int J Obes 37: 16-23.
20. Gough EK, Moodie EE, Prendergast AJ, Johnson S, Humphrey JH, Stoltzfus R, et al. (2014) The impact of antibiotics on growth in children in low and middle income countries: Systematic review and meta- Analysis of randomised controlled trials. BMJ: British Medical Journal 348:g2267. doi: 10.1136/bmj.g2267 PMID: 24735883.
21. Penders J, Kummeling I, Thijs C (2011) Infant antibiotic use and wheeze and asthma risk: A systematic review and meta- Analysis. European Respiratory Journal 38: 295-302. doi: 10.1183/09031936.00105010 PMID: 21233272.
22. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. (2014) Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11: 506- 514.
23. Aureli P, Capurso L, Castellazzi AM, Clerici M, Giovannini M, Morelli L, et al. (2011) Probiotics and health: An evidence-based review. Pharmacological Research 63: 366-376. doi: 10.1016/j.phrs.2011. 02.006 PMID: 21349334.
24. Gerritsen J, Smidt H, Rijkers GT, de Vos WM(2011) Intestinal microbiota in human health and disease: The impact of probiotics. Genes and Nutrition 6: 209-240. doi: 10.1007/s12263-011-0229-7 PMID: 21617937.
25. Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vos WM (2005) Probiotic and other functional microbes: From markets to mechanisms. Curr Opin Biotechnol 16: 204-211. PMID: 15831388.
26. Horvath A, Dziechciarz P, Szajewska H (2011) Meta- Analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 33: 1302- 1310. doi: 10.1111/j.1365-2036.2011.04665.x PMID: 21507030.
27. Segarra-Newnham M (2007) Probiotics for clostridium difficile- Associated diarrhea: Focus on lactobacillus rhamnosus GG and saccharomyces boulardii. Ann Pharmacother 41: 1212-1221. PMID: 17595306.
28. Szajewska H, Wanke M, Patro B (2011) Meta- Analysis: The effects of lactobacillus rhamnosus GG supplementation for the prevention of healthcare- Associated diarrhoea in children. Aliment Pharmacol Ther 34: 1079-1087. doi: 10.1111/j.1365-2036.2011.04837.x PMID: 21899584.
29. Hawrelak JA, Whitten DL, Myers SP (2005) Is lactobacillus rhamnosus GG effective in preventing the onset of antibiotic- Associated diarrhoea: A systematic review. Digestion 72: 51-56. PMID: 16113542.
30. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Białek D (2007) Meta- Analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 25: 871-881. PMID: 17402990.
31. Kim SW, Suda W, Kim S, Oshima K, Fukuda S, Ohno H, et al. (2013) Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high- Throughput pyrosequencing. DNA Res 20: 241-253. doi: 10.1093/dnares/dst006 PMID: 23571675.
32. Lahti L, Salonen A, Kekkonen RA, Salojärvi J, Jalanka-Tuovinen J, Palva A, et al. (2013) Associations between the human intestinal microbiota, lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high- Throughput profiling data. PeerJ 1: E32. doi: 10.7717/peerj.32 PMID: 23638368.
33. Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, et al. (2009) Comparative genomic analysis of lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc Natl Acad Sci USA 106: 17193-17198. doi: 10.1073/pnas.0908876106 PMID: 19805152.
34. Lebeer S, Vanderleyden J, De Keersmaecker SC (2010) Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens. Nature Reviews Microbiology 8: 171-184. doi: 10.1038/nrmicro2297 PMID: 20157338.
35. Plummer SF, Garaiova I, Sarvotham T, Cottrell SL, Le Scouiller S, Weaver M, et al. (2005) Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents 26: 69-74. PMID: 15967639.
36. Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer T, et al. (2006) Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol 57: 239-250. PMID: 16867142.
37. Kumpu M, Kekkonen R, Kautiainen H, Järvenpää S, Kristo A, Huovinen P, et al. (2012) Milk containing probiotic lactobacillus rhamnosus GG and respiratory illness in children: A randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 66: 1020-1023. doi: 10.1038/ejcn.2012.62 PMID: 22692023.
38. Ahlroos T, Tynkkynen S (2009) Quantitative strain-specific detection of lactobacillus rhamnosus GG in human faecal samples by real- Time PCR. J Appl Microbiol 106: 506-514. doi: 10.1111/j.1365-2672. 2008.04018.x PMID: 19200317.
39. Rajilic-Stojanovic M, Heilig HGHJ, Molenaar D, Kajander K, Surakka A, Smidt H, et al. (2009) Development and application of the human intestinal tract chip, a phylogenetic microarray: Analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 11: 1736-1751. doi: 10.1111/j.1462-2920.2009.01900.x PMID: 19508560.
40. Lahti L, Torrente A, Elo LL, Brazma A, Rung J (2013) A fully scalable online pre-processing algorithm for short oligonucleotide microarray atlases. Nucleic Acids Res 41: E110. doi: 10.1093/nar/gkt229 PMID: 23563154.
41. R Core Team (2012) R: A language and environment for statistical computing. Available: http://www.Rproject.org/.
42. Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O'Hara R, et al. (2013) Vegan: Community ecology package. R package version 2.0-6. Available: http://CRAN.R-project.org/package=vegan.
43. Venables W, Ripley B (2002) Modern applied Statistics with S. New York, Springer.
44. Pinheiro J, Bates D, DebRoy S, Sarkar D, the R Development Core Team (2013) Nlme: Linear and Nonlinear mixed effects models. R package version 3.1-108.
45. Therneau TM (2000) Modeling survival data: Extending the cox model. New York, Springer.
46. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700. PMID: 12045108.
47. Louis P, Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294: 1-8. doi: 10.1111/j.1574-6968.2009.01514.x PMID: 19222573.
48. Wexler HM (2007) Bacteroides: The good, the bad, and the nitty-gritty. Clin Microbiol Rev 20: 593- 621. PMID: 17934076.
49. Sepp E, Julge K, Mikelsaar M, Björkstén B (2005) Intestinal microbiota and immunoglobulin E responses in 5-year-old estonian children. Clinical & Experimental Allergy 35: 1141-1146.
50. Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, et al. (2013) Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC Med 11: 46. doi: 10.1186/1741-7015-11-46 PMID: 23433344.
51. de Goffau MC, Fuentes S, van den Bogert B, Honkanen H, de Vos WM, Welling G, et al. (2014) Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 57: 1569-1577. doi: 10.1007/s00125-014-3274-0 PMID: 24930037.
52. Scheepers L, Penders J, Mbakwa C, Thijs C, Mommers M, Arts IC (2015) The intestinal microbiota composition and weight development in children: The KOALA birth cohort study. Int J Obes 39: 16-25.
53. Saitoh S, Noda S, Aiba Y, Takagi A, Sakamoto M, Benno Y, et al. (2002) Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease. Clin Diagn Lab Immunol 9: 54-59. PMID: 11777829.
54. de Goffau MC, Luopajarvi K, Knip M, Ilonen J, Ruohtula T, Härkönen T, et al. (2013) Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes 62: 1238-1244. doi: 10.2337/db12-0526 PMID: 23274889.
55. San Joaquin VH, Griffis JC, Lee C, Sears CL (1995) Association of bacteroides fragilis with childhood diarrhea. Scand J Infect Dis 27: 211-215. PMID: 8539543.
56. Manichanh C, Eck A, Varela E, Roca J, Clemente JC, Gonzales A, et al. (2014) Anal gas evacuation and colonic microbiota in patients with flatulence: Effect of diet. Gut 63: 401-408. doi: 10.1136/gutjnl-2012-303013 PMID: 23766444.